Dopamine
Dopamine receptors (GPCR-A17) are widespread in the body of vertebrates, playing major roles in processes of the central nervous system, as well as in the periphery. In the CNS, dopaminergic neurons are critically involved in voluntary movement, memory, learning, sleep, attention, feeding, and rewarding, Well known examples of disorders as a result of malfunction of the central dopaminergic system are Parkinson’s disease (loss of striatal dopaminergic innervations in the brain), schizophrenia, depression, ADHD, and addiction (among many others). In the periphery, dopamine plays important physiological roles in the regulation of olfaction, retinal processes, hormonal regulation, cardiovascular functions, sympathetic regulation, immune system, renal functions, and more[1]. Five major classes (D1-D5) have been identified thus far, which can be grouped into two sub classes. The group of D1-like receptors (members D1 and D5; all stimulating the second messenger system adenylate cyclase), and the group of D2-like receptors (members D2, D3 and D4; all inhibiting adenylate cyclase). As widespread and abundant as dopaminergic neurons are in the body of vertebrates, as comprehensive and diverse is the list of Axon LigandsTM interacting at all subtypes of dopaminergic receptors (selectively, or specific combinations).
[1] The Physiology, Signaling, and Pharmacology of Dopamine Receptors. J-M Beaulieu, R.R. Gainetdinov. Pharmacol. Rev. 2011, 63, 182-217.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1446 | Ziprasidone hydrochloride | Atypical antipsychotic | €50.00 | |
2424 | WAY 100635 maleate | 5-HT1A antagonist with D4 agonistic properties | €125.00 | |
1086 | WAY 100635 hydrochloride | 5-HT1A antagonist | €125.00 | |
1343 | ST 198 | D3 antagonist | €99.00 | |
1342 | ST 148 | D2 antagonist | €115.00 | |
2115 | Sonepiprazole hydrochloride | Selective dopamine D4 antagonist | €85.00 | |
1236 | SKF 83566 hydrobromide | D1 antagonist | €80.00 | |
1141 | Sertindole | 5-HT2, D2 and α1 adrenoceptor antagonist | €82.00 | |
1920 | SB 277011A | D3 dopamine receptor antagonist | €90.00 | |
1454 | Risperidone | Atypical antipsychotic | €75.00 | |
1354 | Quetiapine fumarate | Atypical antipsychotic | €75.00 | |
1298 | Olanzapine | Atypical antipsychotic | €75.00 | |
1742 | NS 30678 hydrochloride | D2 ligand with surmountable/competitive-like D2 antagonist properties | €115.00 | |
1405 | NNC 756 | D1 antagonist | €140.00 | |
1101 | Molindone hydrochloride | D2 antagonist; MAO inhibitor | €85.00 | |
3378 | Metoclopramide | Dopamine D2 and serotonin 5-HT3 antagonist | €50.00 | |
1802 | JNJ 37822681 dihydrochloride | D2 antagonist | €140.00 | |
1493 | Iloperidone | Atypical antipsychotic | €85.00 | |
3610 | Haloperidol | D2, D3 and D4 antagonist | €60.00 | |
1347 | GR 103691 | D3 antagonist | €90.00 | |
2127 | Fluphenazine decanoate dihydrochloride | Antipsychotic with high affinity for dopamine and serotonin receptors | €60.00 | |
1554 | Droperidol | D2 and α1 adrenoceptor antagonist | €50.00 | |
1975 | Dilept | Neurotensin and dopamine receptor antagonist | €90.00 | |
1087 | Desmethyl-WAY 100635 trihydrochloride | Building Block for labelled 5-HT1A antagonist | €145.00 | |
2353 | Blonanserin | Potent dopamine D2 and serotonin 5-HT2 antagonist | €65.00 | |
1503 | Asenapine maleate | Atypical antipsychotic | €70.00 | |
1381 | Amisulpride | D2 and D3 antagonist | €45.00 | |
2944 | A 381393 | Potent, brain-penetrant, selective antagonist of the dopamine D4 receptor | €125.00 | |
1007 | (R)-5-Hydroxy-DPAT hydrobromide | D2 antagonist | €145.00 |